Cambridge Healthtech Institute

A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderated by: Ho Sung Cho, Ph.D., Chief Technical Officer, Ambrx.

CHI's Fifth Annual Protein-Protein Interactions: Targeting PPI for Therapeutic Interventions will be held April 18-19, 2012 in San Diego as part of the Drug Discovery Chemistry conference. Early registration discount ends January 27th.

Cambridge Healthtech Institute’s Third Annual Anti-Inflammatories: Small Molecule Approaches will be held April 17-18, 2012 in San Diego as part of the Drug Discovery Chemistry conference. Early registration discount expires January 27th.

Over 500 participants to gather in San Diego, California March 5-8 for CHI's Third Annual X-Gen Congress & Expo.

100+ pharma and biotech companies from around the world will participate at CHI's 4th annual Integrated R&D Informatics & Knowledge Management conference to be held in San Francisco, CA on February 21-23, 2012.

A roundtable discussion during the Cancer Biologics Conference at the Tri-Conference. Moderatored by: Gary Starling, Ph.D., Director, GPRD Discovery, Oncology Biologics, Abbott Biotherapeutics Corp.

CHI’s Cancer Biologics conference is a 3-day event based on in-depth research with experts in the field.

Badri Rengarajan, M.D., Medical Director, will present in the modeling and simulation tools to improve Phase III success session.

Hear Drug Discovery Leaders at the Upcoming Molecular Medicine Tri-Conference

Dr. Quackenbush will present in the translating biomarker driven cancer treatments into practice session.